TCRCure Biopharma Ltd.
5 clinical trials · Sponsor
◉ Watch TCRCure Biopharma Ltd.
| Record | Firm | Date |
|---|---|---|
| Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors (NCT07487597) | TCRCure Biopharma Ltd. | 2026-02-28 |
| TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC (NCT07246304) | TCRCure Biopharma Ltd. | 2025-11-30 |
| Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors (NCT07108140) | TCRCure Biopharma Ltd. | 2025-05-20 |
| NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors (NCT05881525) | TCRCure Biopharma Ltd. | 2023-06-01 |
| HPV16 E6 TCR T Cells for Cervical Carcinoma (NCT05357027) | TCRCure Biopharma Ltd. | 2022-08-10 |
Track TCRCure Biopharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.